Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-68,200
Closed -$1M 11449
2025
Q3
$1M Buy
68,200
+47,500
+229% +$484K ﹤0.01% 6310
2025
Q2
$203K Sell
20,700
-43,000
-68% -$356K ﹤0.01% 8515
2025
Q1
$463K Buy
63,700
+30,800
+94% +$269K ﹤0.01% 7016
2024
Q4
$257K Buy
+32,900
New +$271K ﹤0.01% 7981
2024
Q3
Sell
-40,100
Closed -$321K 9765
2024
Q2
$321K Buy
+40,100
New +$358K ﹤0.01% 7701
2024
Q1
Sell
-58,600
Closed -$655K 9423
2023
Q4
$655K Buy
58,600
+40,200
+218% +$370K ﹤0.01% 6302
2023
Q3
$284K Sell
18,400
-101,000
-85% -$1.7M ﹤0.01% 7138
2023
Q2
$2.26M Sell
119,400
-113,200
-49% -$1.99M ﹤0.01% 3984
2023
Q1
$3.54M Buy
+232,600
New +$3.03M ﹤0.01% 2913

Other funds holding ETNB

Jane Street's ETNB Position: Q4 2025 in Review

Jane Street sold out of 89bio (ETNB) in Q4 2025, closing a stake of 428,720 shares — an estimated $6.3M sold.

Jane Street first reported a position in ETNB in Q3 2022 and held it in 11 quarters. The position peaked at $11.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Jane Street reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 428,720 89bio shares in Q4 2025, an estimated $6.3M.
  • Jane Street first reported a position in 89bio in Q3 2022 and held it in 11 quarters.
  • Jane Street's 89bio position peaked at $11.3M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.